At this time, posts about Enzychem Lifesciences are rapidly increasing on portals and securities communities. Today, foreigners have tentatively sold a net 13,000 shares of Enzychem Lifesciences, and institutions have sold a net 3,000 shares. Enzychem Lifesciences is known as a global new drug development and active pharmaceutical ingredient company.

As of 11:30 AM on the 13th, the stock price of Enzychem Lifesciences is 95,000 KRW, down 6.4% from the previous day, with a trading volume of 311,466 shares, which is 150.73% of the 5-day average trading volume.

In addition to Enzychem Lifesciences, posts by investors are also rapidly increasing for Bumyang Geonyeong (002410), SCI Pyeongga Jeongbo (036120), and Hanwha Solutions Preferred (009835).

※Source: AI Investment Assistant AI Racciro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing